tm
Seeing Is Believing
tm
Seeing Is Believing
BBI is currently covered by 2 analysts
Brickell Biotech's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of BBI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 9.67 days.
Highest price target for BBI is $8, Lowest price target is $3.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HCWAINWRIGHT on 16-Aug-2022. First documented stock forecast 18-Jan-2022.
Currently out of the existing stock ratings of BBI, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$4.5
$3.53 (363.92%)
4 years 30 days ago
(16-Aug-2022)
0/1 (0%)
$1.04 (30.06%)
Buy
$11.25
$10.35 (1150.00%)
4 years 4 months 2 days ago
(13-May-2022)
0/1 (0%)
$2.87 (34.25%)
Buy
$35
4 years 5 months 30 days ago
(16-Mar-2022)
1/1 (100%)
$-5.01 (-12.52%)
29
What is BBI (Brickell Biotech) average time for price targets to be met?
Which analyst most recently updated their price target on BBI (Brickell Biotech)?
Which analyst has the current lower performing score on BBI (Brickell Biotech) with a proven track record?
Which analyst has the most public recommendations on BBI (Brickell Biotech)?
Which analyst is the currently most bullish on BBI (Brickell Biotech)?
Which analyst is the currently most reserved on BBI (Brickell Biotech)?
